ABITEC Launches New Versatile Excipient for Oral Dosage Applications

ABITEC has announced the launch of a new and versatile excipient for oral dosage applications to meet industry demands and bring innovative technologies to the pharmaceutical industry.

ABITEC’s CAPMUL® GDB EP/NF is a monographed glyceryl dibehenate utilized for a range of dosing solutions. CAPMUL GDB EP/NF is a high-purity, highly-reproducible solid lipid excipient which offers good flow and uniform particle size distribution for use in multiple formulations, including tablets, hard gels, softgels, solid lipid nanoparticles, nano-structured lipids, granulations, multi-particulates, extrudates, congealing, and liquids. ABITEC is dedicated to developing high quality lipid excipients for use globally in a range of diversified pharmaceutical applications.

ABITEC’s trademarked specialty lipids include Capmul®, Captex®, Caprol®, Acconon®, Sterotex®, Nutri Sperse®, Hydro~Kote® and Pureco®. Product application areas vary from pharmaceutical, nutritional and cosmetic products, to the manufacturing of foams, creams, ointments and lotions. These ingredients are produced in the USA under cGMP manufacturing.

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!

  • <<
  • >>

Join the Discussion